Zahm, Chris D.
Johnson, Laura E.
McNeel, Douglas G.
Funding for this research was provided by:
Prostate Cancer Foundation (2014 Movember PCF Challenge Award)
National Cancer Institute (R01 CA219154, P30 CA014520)
Article History
Received: 22 February 2019
Accepted: 6 September 2019
First Online: 12 October 2019
Compliance with ethical standards
:
: Douglas G. McNeel has ownership interest, has received research support, and serves as consultant to Madison Vaccines, Inc. which has licensed intellectual property related to this content. None of the other authors have relevant potential conflicts of interest.
: Long-term use of blood samples collected from research subjects who had previously consented for remaining samples to be used for immunology-related research was approved on 11/21/2016 under University of Wisconsin IRB protocol 2013-0126-CR004 as a minimal risk protocol, not requiring additional patient consent.
: Samples were collected under University of Wisconsin IRB-approved protocols, and all patients gave written, informed consent for remaining samples to be used for research.